Biora Therapeutics To Present On The BioJet Systemic Oral Delivery Platform At The Next Gen Peptide Formulation & Delivery Summit 2024
$BIOR
Biotechnology: Pharmaceutical Preparations
Health Care
Biora Therapeutics, Inc. (NASDAQ:BIOR), the biotech company that is reimagining therapeutic delivery, today announced that it will present preclinical data from the BioJet™ Systemic Oral Delivery Platform at the Next Gen Peptide Formulation & Delivery Summit, which will take place June 18–20, 2024 in Boston.
Details of the presentation are as follows:
| BPresentation Title: | Empowering Peptide Self Administration with Needle-Free Smart Capsules |
| Track: | Pioneering Devices to Increase the Reach of Peptide APIs |
| Date & Time: | Wednesday, June 19, 2024 from 2:15 to 2:45 PM Eastern time |
| Presenting Author: | Sharat Singh, PhD, Head of Research, Biora Therapeutics, Inc. |
Dr. Singh will also participate in a panel discussion on June 19 at 8:45 AM titled "Uncovering Innovations in Peptide Drug Delivery & Formulation for Improved Bioavailability," alongside representatives from Eli Lilly, Merck, and Novo Nordisk.